Saxenda Approved?

Discussion in 'Novo Nordisk' started by Anonymous, Sep 11, 2014 at 9:29 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Is Saxenda approved yet?

    All I hear is crickets chirping......
     

  2. Anonymous

    Anonymous Guest

    Ups, I guess somebody did know ?
     
  3. Anonymous

    Anonymous Guest

    We need to work on Brown Fat my favorite for energy.
     
  4. Anonymous

    Anonymous Guest

    Yeah, let's find a brown sh!t small molecule lead that we can turn into a peptide, go for it Novo.
     
  5. Anonymous

    Anonymous Guest

    will saxenda be managed in the specialty channel?
     
  6. Anonymous

    Anonymous Guest

    Shouldn't you wait until it is approved before you start worrying about this?
     
  7. Anonymous

    Anonymous Guest

    No worries. It is normal procedure with a couple of years between a favorable vote and approval.
     
  8. Anonymous

    Anonymous Guest

    Take it easy. Approval is imminent. No later than sometimes in 2015.
     
  9. Anonymous

    Anonymous Guest

    What happened to the analyst's predictions of a 2014 approval that we bombarded with?
     
  10. Anonymous

    Anonymous Guest

    Still a couple of weeks to go. But it doesn't really matter. We have Degludec approval coming up no later than 2017. Or perhaps 2018.
     
  11. Anonymous

    Anonymous Guest

    You're leaving out DegludLira in 2018, and oral insulin in the same year, 2019 at the absolute latest. I tell you, NO ONE in this, or any other industry has a pipeline like ours!!
     
  12. Anonymous

    Anonymous Guest

    Vitamin V hasn't come close to hitting its peak, Saxenda's imminent approval, closely followed by Degludec, Deglu-Lira, and oral insulin all mean job security for the next 15 years at least.
     
  13. Anonymous

    Anonymous Guest

    Tick tock.....tick tock...tick tock....
     
  14. Anonymous

    Anonymous Guest

    Really? Who is paying for a $900 monthly cosmetic improvement when you have at least 5 weight loss options under $150 cash price? Oh commercial? What payers are jumping on that train?

    Deguldec? Didn't we have that launch meeting? Bunch of idiots. By the time FDA approves that injectable we will be the third me-too in the basal launch series of new therapies...Awesome.

    Deglu-Lira...Sanofi will be out first. Another fine opportunity lost by the Danes not knowing how to gain approval in the US market space.

    Oral insulin? Now that is a real pipe dream there. By then NovoLog, Humalog and Apidra will be generic and at a minimum insurance won't cover the price Novo will surely want to tag it with...

    15 years. LOL. Top heavy as it is. May the morale improve until the PIPs take effect.
     
  15. Anonymous

    Anonymous Guest

    Apparently this person does not understand the sarcasm of the previous poster. Must be from the South.
     
  16. Anonymous

    Anonymous Guest

    So how come our CEO maintains we have by far the best pipeline of the industry ?
     
  17. Anonymous

    Anonymous Guest

    Nice pipeline, execution sucks.
     
  18. Anonymous

    Anonymous Guest

    I dropped in post #72. I was being facetious. But your analysis is spot-on IMHO. As a result, you will soon draw an acerbic retort from our favorite Scudder Mill sycophant.
     
  19. Anonymous

    Anonymous Guest

    Not sure if we are going to keep ahead. Looks like Lilly, Sanofi and perhaps even Merck are coming into the game strongly.
     
  20. Anonymous

    Anonymous Guest

    I think sarcasm in under appreciated on this site. However, don't assume that just because someone disagrees with you means they are a home office plant. There are some of us who feel like we've got a pretty good thing going here at NNI. I think we're each entitled to our own opinion, right?